European equities traded in the US as American depositary receipts were trending slightly lower late Monday morning, declining 0.16% to 1,278.01 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk (NVO) and semiconductor company Sequans Communications (SQNS), which rose 3.2% and 2.8% respectively. They were followed by medical device maker EDAP TMS (EDAP) and accommodations booking company trivago (TRVG), which were up 2.7% and 1.5% respectively.
The decliners from continental Europe were led by furniture maker Natuzzi (NTZ), which fell 2.9%, followed by biotech firm Evaxion Biotech (EVAX) and internet advertising firm Criteo (CRTO), which lost 2.3% each. They were followed by 3D printer company Materialise (MTLS), which was down 2%.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Verona Pharma (VRNA) and TC Biopharm (TCBP), which rose 3.7% and 3.1% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and software firm Endava (DAVA), which increased 2.1% and 1.8% respectively.
The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and biotech firm Autolus Therapeutics (AUTL), which dropped 4.3% and 3.5% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which lost 3.3% and 3.2% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。